Evidence map›Paper›PMID 25709890›Full record

ArticleLeukemia research reports2015

Emergence of a STAT3 mutated NK clone in LGL leukemia.

Yiyi Yan, Thomas L Olson, Susan B Nyland, David J Feith, Thomas P Loughran

Open access · goldAbstract read
In one paragraph

Article in Leukemia research reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Clinical relevance of mosaic variants detected by exome sequencing.The Journal of allergy and clinical immunology · 2026
    Article
  2. How Genomic and Structural Context Could Shape JAK-STAT Variant Pathogenicity.Twin research and human genetics : the official journal of the International Society for Twin Studies · 2026
    Article
  3. STAT3 SH2 Domain Aspartic Acid 661 Mutations Activate Immune Gene Programs.Journal of cellular and molecular medicine · 2026
    Article
  4. ActivatingFrontiers in immunology · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yiyi YanDepartment of Medicine, York Hospital, York, PA, USA.
Thomas L OlsonUniversity of Virginia Cancer Center, P.O. Box 800334, Charlottesville, VA 22908-0334, USA.
Susan B NylandUniversity of Virginia Cancer Center, P.O. Box 800334, Charlottesville, VA 22908-0334, USA.
David J FeithUniversity of Virginia Cancer Center, P.O. Box 800334, Charlottesville, VA 22908-0334, USA.
Thomas P LoughranUniversity of Virginia Cancer Center, P.O. Box 800334, Charlottesville, VA 22908-0334, USA.
University of Virginia · USUniversity of Virginia Cancer CenterYork General Hospital · US

Funding

Tissue Repository and Animal Models CoreP01CA171983 · NCI · UNIVERSITY OF VIRGINIA · PI LOUGHRAN, THOMAS P. · 2013 to 2024
$19.9M
Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
Survival Mechanisms in Leukemic NK CellsR01CA098472 · NCI · UNIVERSITY OF VIRGINIA · PI LOUGHRAN, THOMAS P. · 2003 to 2016
$4.0M
Characterization of the LGL Leukemia Virus (PQ 12)R01CA170334 · NCI · UNIVERSITY OF VIRGINIA · PI LOUGHRAN, THOMAS P., POSS, MARY L. · 2012 to 2015
$1.6M
NCI NIH HHS P01 CA171983NCI NIH HHS R01 CA098472NCI NIH HHS R01 CA170334NCI NIH HHS T32 CA009109
6 · The paper itself

Abstract

Large granular lymphocyte (LGL) leukemia is a chronic clonal lymphoproliferative disorder. Here, a T-LGL leukemia patient developed NK-LGL leukemia with residual leukemic T-LGL. TCRVβ usage and CDR3 sequence drifts were observed with disease progression. A STAT3 S614R mutation was identified in NK but not T-cells in the mixed leukemic stage. Multiple, non-dominant T-cell clones with distinct STAT3 mutations were present throughout. Our results suggest that T and NK-LGL leukemia may share common pathogenesis mechanisms and that STAT3 mutation alone is insufficient to bring about clonal expansion. Mutational and immunological monitoring may provide diagnostic and therapeutic significance in LGL leukemia.

Indexed as

ClassificationsClonal evolutionLeukemia markersMutation detectionT cell receptor

Identifiers

PMID25709890
PMCPMC4327758
OpenAlexW2036603042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.